* * * * *
* Youreable.com services for disabled people DirectGov * *
*
* Home * Life * Shopping * News * Community *
* * * * * *
* **Headlines***Features*
* *
* * * * * *
*
Search



Log InRegister Here
*
£50,000 for right idea
*
*
Sun illuminates sexuality taboo
*
*
MS trial takes off
*
*
Big Brother’s Tim admits parking bay abuse
*
*
Cautious welcome for cannabis rethink
*
*
Cut the mental health wait
*
*
*
* * *
* * Contact us * *
* * *
*
* * *
* * Press * *
* * *
*
* * *
* * Accessibility * *
* * *
*
* * *
* * Advertise with Us * *
* * *
*
*
MS trial takes off

Researchers are launching a trial to test whether the early use of an experimental drug can reduce long-term disability caused by multiple sclerosis.

Scientists are recruiting 180 volunteers with "early aggressive" relapsing-remitting multiple sclerosis (MS) to take part in the five-year trial of the antibody Campath-1H.

The antibody has already shown it can achieve a dramatic reduction in relapse rate for some people with an advanced form of the condition known as secondary progressive MS.

But the researchers, from the University of Cambridge and Addenbrooke?s Hospital, hope it might also stop the build-up of damage that leads from relapsing-remitting MS to this more serious form of the condition, if people are treated early enough.

One-third of the volunteers will receive the MS drug beta interferon, to compare its effectiveness with its "competitor".

Alasdair Coles, one of the researchers, said it would take about seven years before the final results were available.

He said: "What we all want to know is: can any treatment reduce disability in the long term?"

For information, contact the MS Trust, tel: 01462 476700.

Posted: 11 July, 2002

[Disability Now logo]For DN news and subscriptions click here...
Search for other articles like this
Google
 
About us * Our partners * Terms & conditions * Jobs at Youreable
*
designed by pixelpark
* Sirus Automotive Greater London Authority Jobs DirectGov Environment Agency *
*